If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Digital Technology » Investment Benchmarks
Download FREE Excerpt
7 Info Graphics
17 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
As the use of digital marketing grows across the pharmaceutical industry, marketing leaders continue to search for ways to demonstrate the value of digital to internal stakeholders and executives.
This research identifies which digital activities are best for measuring return on investment and the tactics that drive the greatest ROI. The study also provides benchmarks for when in the product lifecycle organizations begin digital marketing activities and when in the product lifecycle marketing leaders see the highest impact or return. Digital marketing leaders can use this study to compare their approach for measuring ROI with their digital peers.
This study provides segment perspectives on large, mid-cap and small companies as well as global vs. U.S.-only companies.
This research engaged 39 digital marketing leaders from 30 leading pharmaceutical, biotech, and life sciences companies. Thirteen study participants represent large pharma organizations, while the remaining benchmark class represent medium or small companies.
Pharmaceutical; Medical Device; Biotech; Manufacturing; Consumer Products; Diagnostic; Health Care; Marketing; Biopharmaceutical; Clinical Research; Laboratories; Chemical
Novartis; Bristol-Myers Squibb; Roche; Astellas; Bayer; Teva Pharmaceutical Industries Ltd; Mylan; Ipsen; Alcon; Abbott; Eisai; Triplefin; Sanofi; cipla; Merck; Ferring Pharmaceuticals; Boehringer Ingelheim; Biogen; UCB Pharma; Hospira; Johnson & Johnson; GlaxoSmithKline ; Baxter Healthcare; Olympus Corporation; Sun Pharmaceutical; AstraZeneca; Abbvie; Genentech; Clarus Therapeutics; Zydus
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.